If you’ve ever had your insulin levels checked or wondered why some people are resistant to the hormone while others aren't, you owe a debt to Jesse Roth. He didn't just study diabetes. He fundamentally rewired the way medicine views how cells talk to each other. Dr. Roth passed away recently at the age of 91, leaving behind a legacy that defines modern endocrinology.
Most people think of diabetes as a simple lack of insulin. That’s only half the story. Before Roth’s work at the National Institutes of Health (NIH) in the 1960s and 70s, the scientific community was mostly staring at the "sender" of the message—the pancreas. Roth decided to look at the "receiver." He proved that for a hormone to work, it has to bind to a specific receptor on the surface of a cell. It sounds obvious now. Back then, it was a total shift in how we understood biology.
The Man Who Found the Missing Link in Cell Communication
Jesse Roth wasn't interested in following the pack. He wanted to know why some patients had plenty of insulin in their blood but still suffered from high blood sugar. This led him and his team, including brilliant collaborators like Ira Pastan and C. Ronald Kahn, to the discovery of the insulin receptor.
Think of insulin as a key. If you have a pile of keys but the lock is jammed or missing, you’re not getting into the house. Roth identified the "lock." By developing ways to measure these receptors, he showed that type 2 diabetes is often a problem of the cell’s inability to respond to the hormone, rather than a lack of the hormone itself. This is the bedrock of what we now call insulin resistance.
His work went way beyond the pancreas. He suggested that these biochemical communication systems weren't just for complex humans but existed in primitive organisms like bacteria and yeast. This implies that the "language" of hormones is one of the oldest features of life on Earth. It’s a staggering thought. The same basic signaling happens in a single-celled microbe and in your own body right now.
Why the NIH Golden Era Mattered
Roth flourished during what many call the "Golden Era" of the NIH. This was a time when the brightest minds had the freedom and funding to chase "big " questions without the immediate pressure of commercializing a drug. As the chief of the Diabetes Section and later the scientific director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Roth mentored a generation of scientists.
You can't talk about Roth without talking about the people he trained. His lab was a pressure cooker of intellectual curiosity. He had a knack for spotting talent and pushing researchers to think about the "why" instead of just the "how." Many of his protégés went on to lead major medical institutions or win prestigious awards themselves. He didn't just produce papers; he produced the people who would lead 21st-century medicine.
His approach was always about the patient. Even when he was neck-deep in molecular biology, he stayed focused on how these tiny receptors affected the person sitting in the clinic. He understood that you couldn't fix a disease if you didn't understand the fundamental physics of the interaction between a chemical and a cell.
The Shift to Geriatric Medicine and Late Career Brilliance
Most legends start to coast when they hit their 60s. Roth did the opposite. After a stellar career at the NIH, he moved to Johns Hopkins University and later to the Northwell Health system. He shifted a lot of his focus to aging.
He realized that as we get older, our signaling systems start to fray. He spent years investigating how the communication between cells breaks down over time and how that contributes to the frailty we see in the elderly. He remained an active, sharp-witted presence in the lab well into his late 80s. He never lost that spark.
He was also known for his incredible memory and his ability to recall obscure studies from decades ago. In meetings, he’d often cite a paper from the 1950s to prove a point about a modern experiment. It wasn't about showing off. He truly believed that science is a long, continuous thread and you have to know where the thread started to know where it's going.
Lessons from the Life of Jesse Roth
What can we take away from a life like his? First, don't just look where everyone else is looking. While the world was obsessed with insulin production, Roth looked at the cell surface. That’s where the real answers were hiding.
Second, mentorship is a multiplier. Roth’s individual discoveries were massive, but his impact is ten times larger because of the scientists he trained. If you're in a leadership position, your greatest "output" isn't your work—it's the people you leave behind who are better because of you.
Third, stay curious. Roth never stopped asking questions. He didn't see "diabetes" as a solved problem or "aging" as an inevitable decline that didn't need explaining. He saw them as puzzles that required better tools and fresher eyes.
If you’re managing diabetes today or taking medications that sensitize your body to insulin, you’re living in a world Jesse Roth built. He transformed a vague understanding of "blood sugar" into a precise science of molecular locks and keys.
Keep an eye on the latest research coming out of the NIDDK or the American Diabetes Association. Much of the work being done on "receptor kinetics" and "cell signaling" is just the next chapter of the book Roth started writing over fifty years ago. Use his story as a reminder that sometimes, to solve a big problem, you have to look at the smallest possible interaction.
